Pharmaceutical advertising versus research spending: Are profits more important than patients?

被引:7
作者
Mukherjee, D
Topol, EJ
机构
[1] Cleveland Clin Fdn, Dept Cardiovasc Med, Cleveland, OH 44195 USA
[2] Univ Michigan Hlth Syst, Univ Hosp, Ann Arbor, MI USA
关键词
D O I
10.1016/S0002-8703(03)00399-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:563 / 564
页数:2
相关论文
共 15 条
[1]  
*C REC, 2002, P DEB 107 C 2 SESS U
[2]   Role of prostacyclin in the cardiovascular response to thromboxane A2 [J].
Cheng, Y ;
Austin, SC ;
Rocca, B ;
Koller, BH ;
Coffman, TM ;
Grosser, T ;
Lawson, JA ;
FitzGerald, GA .
SCIENCE, 2002, 296 (5567) :539-541
[3]  
Frisch E, 2002, CLEV CLIN J MED, V69, P568, DOI 10.3949/ccjm.69.7.568
[4]   Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries [J].
Hennan, JK ;
Huang, JB ;
Barrett, TD ;
Driscoll, EM ;
Willens, DE ;
Park, AM ;
Crofford, LJ ;
Lucchesi, BR .
CIRCULATION, 2001, 104 (07) :820-825
[5]   ADVERTISING - INFORMATIONAL BUT NOT EDUCATIONAL [J].
INGELFINGER, FJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1972, 286 (24) :1318-+
[6]  
LEACOCK S, 1924, GARDEN FOLLY
[7]  
*MERCK CO, 2002, 2001 ANN REP
[8]   Risk of cardiovascular events associated with selective COX-2 inhibitors [J].
Mukherjee, D ;
Nissen, SE ;
Topol, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08) :954-959
[9]  
*NIH, 2001, PRESCR DRUGS MASS ME
[10]  
*PHARM, 2002, PHARM 2001 ANN REP